SARS-CoV-2-Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
Files
Publication date
2021-12
Authors
Schulz, Claudia
Martina, Byron
Mirolo, Monica
Müller, Elisabeth
Klein, Ruth
Volk, Holger
Egberink, Herman F.
Gonzalez-Hernandez, Mariana
Kaiser, Franziska
von Köckritz-Blickwede, Maren
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
We conducted a severe acute respiratory syndrome coronavirus 2 antibody seroprevalence study among >2,000 domestic cats from 4 countries during the first coronavirus disease wave in Europe. We found 4.4% seroprevalence using a virus neutralization test and 4.3% using a receptor-binding domain ELISA, demonstrating probable human-to-cat transmission.
Keywords
Animals, Antibodies, Viral, COVID-19, Cats, Europe/epidemiology, Humans, SARS-CoV-2, Seroepidemiologic Studies, SDG 3 - Good Health and Well-being
Citation
Schulz, C, Martina, B, Mirolo, M, Müller, E, Klein, R, Volk, H, Egberink, H, Gonzalez-Hernandez, M, Kaiser, F, von Köckritz-Blickwede, M & Osterhaus, A 2021, 'SARS-CoV-2-Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe', Emerging Infectious Diseases, vol. 27, no. 12, pp. 3115-3118. https://doi.org/10.3201/eid2712.211252